covid
Buscar en
Revista Colombiana de Cardiología
Toda la web
Inicio Revista Colombiana de Cardiología Feocromocitoma bilateral: la importancia de los estudios de diagnóstico por ima...
Journal Information
Vol. 18. Issue 5.
Pages 288-292 (August - October 2011)
Share
Share
Download PDF
More article options
Vol. 18. Issue 5.
Pages 288-292 (August - October 2011)
Open Access
Feocromocitoma bilateral: la importancia de los estudios de diagnóstico por imagen
Bilateral pheochromocytoma: the importance of imaging studies
Visits
2498
Igor I. Bonnet1,
Corresponding author
igorbonnet@live.com

Correspondencia: Bocagrande, Edificio Seguros Bolívar, local 11. Cartagena, Colombia.
, Aiken F. Betancourt2,
Corresponding author
aikenbet@hotmail.com

Correspondencia: Bocagrande, Edificio Seguros Bolívar, local 11. Cartagena, Colombia.
, Javier Segovia2, Fernando Manzur2,3
1 Nucleodiagnóstico Ltda., Cartagena, Colombia
2 Facultad de Medicina, Universidad de Cartagena. Cartagena, Colombia
3 Nuevo Hospital de Bocagrande. Cartagena, Colombia
This item has received

Under a Creative Commons license
Article information

Se presenta un caso clínico poco frecuente de feocromocitoma bilateral, en el cual los estudios de diagnóstico por imagen, tanto de información estructural como funcional, constituyeron una fuente fundamental para su detección y seguimiento.

Palabras clave:
hipertensión arterial
feocromocitoma

We report a rare case of bilateral pheochromocytoma, in which imaging studies, both of structural and functional information, were a major source for its detection and follow-up.

Key words:
hypertension
pheochromocytoma
Full text is only aviable in PDF
Bibliografía
[1.]
M. Ariton, C.S. Juan, T.W. AvRuskin.
Pheochromocytoma: clinical observations from Brooklyn tertiary hospital.
Endocr Pract, 6 (2000), pp. 249-252
[2.]
M. Omura, J. Salto, K. Yamaguchi, et al.
Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.
Hypertens Res, 27 (2004), pp. 193-202
[3.]
S. Werbel, P. Ober.
Pheochromocytoma. Update on diagnosis, localization and management.
Med Clin North Am, 79 (1995), pp. 131-153
[4.]
E.L. Bravo, R. Tagle.
Pheochromocytoma: state-of-the-art and future prospects.
Endocr Rev, 24 (2003), pp. 539-553
[5.]
J.E. Donckier, L. Michel.
Pheochromocytoma: state-of-the-art.
Act Chir Belg, 110 (2010), pp. 140-148
[6.]
J.P. Montagne, H.Y. Kressel, M. Korobkin, et al.
computed tomography of the normal adrenal gland.
AJR Am J Roentgenol, 130 (1978), pp. 963-966
[7.]
G. Wilms, A. Baert, G. marchal, et al.
Computed tomography of the normal adrenal glands: correlative study with autopsy specimens.
J Comput Assist Tomogr, 3 (1979), pp. 467-469
[8.]
W.S. Hayes, A.J. Davidson, P.M. Grimley, et al.
Extra adrenal retroperitoneal paraganglioma: cinical, pathologic, and CT findings.
AJR Am J Roentgenol, 155 (1990), pp. 1247-1250
[9.]
M.A. Blake, M.K. Kalra, M.M. Maher, et al.
Pheochromocitoma: an imaging chameleon.
Radiographics, 24 (2004), pp. S87-S89
[10.]
D.G. Mitchell, M. Crovello, T. Matteucci, R.O. Petersen, M.M. Miettinen.
Benign adrenocortical masses: diagnosis with chemical shift MR imaging.
Radiology, 185 (1992), pp. 345-351
[11.]
J.C. Varghese, P.F. Hahn, N. Papanicolau, W.W. Mayo-Smith, J.A. Gaa, M.J. Lee.
MR differentiation or pheochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times.
Clin Radiol, 52 (1997), pp. 603-606
[12.]
R.A. Bowerman, T.M. Silver, M.H. Jaffe, et al.
Sonography of adrenal pheochromocytomas.
AJR, 137 (1981), pp. 1227-1231
[13.]
D.M. Wieland, J. Wu, L.E. Brown, et al.
Radiolabeled adrenergic neuro-blocking agents: adrenomedulallary Imaging with [131I] iodobenziylguanidine.
J Nucl Med, 21 (1980), pp. 349-353
[14.]
B. Shapiro, J. Copp, J. Sisson, P. Eyre, J. Wallis, W. Beierwaltes.
Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: Experience in 400 cases.
J Nucl Med, 26 (1985), pp. 576-585
[15.]
E. Zapanti, I. Ilias.
Pheochromocytoma: physiopathologic implications and diagnostic evaluation.
Ann Ny Acad Sci, 1068 (2006), pp. 346-360
[16.]
T.W. Valk, M.S. Frager, M.D. Gross, et al.
Spectrum of pheochromocytoma in multiple endocrine neoplasia: a scintigraphic portrayal using 131I-metaiodobenzylguanidine.
Ann Intern Med, 94 (1981), pp. 762-767
[17.]
K.K. Solanki, J. Bomanji, J. Moyes, et al.
A pharmacological guide to medicines wich interfere with biodistribution of radiolabeled meta-iodobenzylguanidine (MIBG).
Nucl Med Commun, 13 (1992), pp. 513-521
[18.]
M. Nakajo, B. Shapiro, J. Copp, et al.
The normal and abnormal distribution of the adrenomedullary imaging agent m-(I-131)iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
J Nucl Med, 24 (1983), pp. 672-682
[19.]
E. van der Harst, W.W. de Herder, H.A. Bruining, H.J. Bonjer, R.R. de Krijger, S.W. Lamberts, et al.
[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas.
J Clin Endocrinol Metab, 86 (2001), pp. 685-693
[20.]
S. Khan, Z. Win, T. Szysko, C. Lloyd, J. Dunn, A. Alavi, A. Nahhas.
Pet imaging of pheochromocytoma.
PET Clin, 2 (2008), pp. 341-349
[21.]
F. Kikuchi, H. Imachi, K. Murao, T. Ohyama, Y. Miyai, Y. Kushida, et al.
Positron emission tomography with 18f-fluorodeoxyglucose is a useful tool for the diagnosis of pheochromocytomas without distant metastasis, where malignancy is suspected on the basis of histopathologic analysis.
Am J Med Sci, 340 (2010), pp. 160-163
Copyright © 2011. Sociedad Colombiana de Cardiología y Cirugía Cardiovascular
Download PDF
Article options